Logo image of VALN

VALNEVA SE - ADR (VALN) Stock Price, Quote, News and Overview

NASDAQ:VALN - Nasdaq - US92025Y1038 - ADR - Currency: USD

5.67  -0.13 (-2.24%)

VALN Quote, Performance and Key Statistics

VALNEVA SE - ADR

NASDAQ:VALN (6/30/2025, 8:00:02 PM)

5.67

-0.13 (-2.24%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High8.66
52 Week Low3.62
Market Cap482.13M
Shares85.03M
Float73.55M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)08-12 2025-08-12
IPO06-28 2007-06-28


VALN short term performance overview.The bars show the price performance of VALN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

VALN long term performance overview.The bars show the price performance of VALN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of VALN is 5.67 USD. In the past month the price decreased by -11.41%. In the past year, price decreased by -19.57%.

VALNEVA SE - ADR / VALN Daily stock chart

VALN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.07 327.88B
AMGN AMGEN INC 13.45 150.13B
GILD GILEAD SCIENCES INC 14.32 137.91B
VRTX VERTEX PHARMACEUTICALS INC N/A 114.33B
REGN REGENERON PHARMACEUTICALS 11.85 56.68B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 42.52B
ARGX ARGENX SE - ADR 95.86 33.66B
ONC BEONE MEDICINES LTD-ADR 6.18 26.19B
BNTX BIONTECH SE-ADR N/A 25.59B
NTRA NATERA INC N/A 23.07B
BIIB BIOGEN INC 7.94 18.40B
INSM INSMED INC N/A 18.33B

About VALN

Company Profile

VALN logo image Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. The company is headquartered in Saint-Herblain, Pays De La Loire and currently employs 695 full-time employees. The company went IPO on 2007-06-28. The firm's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The firm has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The firm is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

Company Info

VALNEVA SE - ADR

6 rue Alain Bombard

Saint-Herblain PAYS DE LA LOIRE FR

CEO: Thomas Lingelbach

Employees: 695

VALN Company Website

VALN Investor Relations

Phone: 33228073710

VALNEVA SE - ADR / VALN FAQ

What is the stock price of VALNEVA SE - ADR today?

The current stock price of VALN is 5.67 USD. The price decreased by -2.24% in the last trading session.


What is the ticker symbol for VALNEVA SE - ADR stock?

The exchange symbol of VALNEVA SE - ADR is VALN and it is listed on the Nasdaq exchange.


On which exchange is VALN stock listed?

VALN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for VALNEVA SE - ADR stock?

12 analysts have analysed VALN and the average price target is 17.26 USD. This implies a price increase of 204.4% is expected in the next year compared to the current price of 5.67. Check the VALNEVA SE - ADR stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is VALNEVA SE - ADR worth?

VALNEVA SE - ADR (VALN) has a market capitalization of 482.13M USD. This makes VALN a Small Cap stock.


How many employees does VALNEVA SE - ADR have?

VALNEVA SE - ADR (VALN) currently has 695 employees.


What are the support and resistance levels for VALNEVA SE - ADR (VALN) stock?

VALNEVA SE - ADR (VALN) has a support level at 5.61 and a resistance level at 5.94. Check the full technical report for a detailed analysis of VALN support and resistance levels.


Is VALNEVA SE - ADR (VALN) expected to grow?

The Revenue of VALNEVA SE - ADR (VALN) is expected to grow by 6.9% in the next year. Check the estimates tab for more information on the VALN EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy VALNEVA SE - ADR (VALN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does VALNEVA SE - ADR (VALN) stock pay dividends?

VALN does not pay a dividend.


When does VALNEVA SE - ADR (VALN) report earnings?

VALNEVA SE - ADR (VALN) will report earnings on 2025-08-12.


What is the Price/Earnings (PE) ratio of VALNEVA SE - ADR (VALN)?

VALNEVA SE - ADR (VALN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.15).


What is the Short Interest ratio of VALNEVA SE - ADR (VALN) stock?

The outstanding short interest for VALNEVA SE - ADR (VALN) is 0% of its float. Check the ownership tab for more information on the VALN short interest.


VALN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

VALN Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to VALN. VALN may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

VALN Financial Highlights

Over the last trailing twelve months VALN reported a non-GAAP Earnings per Share(EPS) of -1.15. The EPS decreased by -184.21% compared to the year before.


Industry RankSector Rank
PM (TTM) 15.08%
ROA 7.48%
ROE 20.65%
Debt/Equity 1.06
Chartmill High Growth Momentum
EPS Q2Q%-114.63%
Sales Q2Q%50.31%
EPS 1Y (TTM)-184.21%
Revenue 1Y (TTM)17.86%

VALN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to VALN. The Buy consensus is the average rating of analysts ratings from 12 analysts.

For the next year, analysts expect an EPS growth of -597.38% and a revenue growth 6.9% for VALN


Ownership
Inst Owners23.31%
Ins Owners0.22%
Short Float %0%
Short Ratio0.02
Analysts
Analysts83.33
Price Target17.26 (204.41%)
EPS Next Y-597.38%
Revenue Next Year6.9%